Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse ev...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Lorenzo Braghieri, Ahmad Gharaibeh, Lubika Nkashama, Abdelrahman Abushouk, Osama Abushawer, Amir Mehdizadeh‐Shrifi, Bianca Honnekeri, Cassandra Calabrese, Venu Menon, Pauline Funchain, Patrick Collier, Diego Sadler, Rohit Moudgil
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Oxford University Press 2025-04-01
Serie:	ESC Heart Failure
Ämnen:	Immune‐checkpoint inhibitor Cardio‐oncology ICI‐related myocarditis
Länkar:	https://doi.org/10.1002/ehf2.15131
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!